COVID Vaccines Begin Rollout as Medicare Announces Coverage

Original story posted on: December 15, 2020

Moderna’s vaccine is expected to be shipped to providers nationwide, on the heels of Pfizer’s.

A reeling nation couldn’t have asked for a better Christmas present.

The Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine for individuals 16 and older last week – a development expected to be repeated for Moderna’s vaccine this week, with others still to follow – as the initial doses began being shipped to healthcare facilities nationwide amid the soaring heights of a nearly yearlong global viral pandemic that has hit the United States disproportionately hard.

Both vaccines have been estimated at approximately 94-95 percent effectiveness, surpassing expectations and offering a glimmer of hope at the end of a rough year.

The Centers for Medicare & Medicaid Services (CMS) issued a MLN Connects Special Edition advisory on Monday, noting that Medicare will cover and pay for the administration of any vaccine furnished consistent with the EUA. The advisory also directed providers to only bill for the vaccine administration codes when submitting claims to Medicare; providers should not include the vaccine product codes when the vaccines are free of charge.

“Today’s announcement is a historic turning point in the fight against the virus – the beginning of the end of this chapter in our world’s history has arrived,” CMS Administrator Seema Verma said in a statement issued shortly after Pfizer’s EUA approval. “Our hearts and minds continue to be with those who have lost loved ones, and I urge states to prioritize nursing homes and vulnerable seniors in their distribution of the vaccine. As we approach more widespread distribution, all Americans can take comfort in the fact that CMS has laid the groundwork to guarantee that every American can get the vaccine for free.”

The COVID-19 pandemic has resulted in nearly 75 million cases and 1.6 million deaths worldwide, with the U.S. alone accounting for nearly 17 million cases and more than 300,000 deaths. New cases that numbered about 50,000 daily during the initial stages of the pandemic, domestically, have soared to more than 200,000 during the last two weeks.

To view a Pfizer fact sheet regarding the administration of its vaccine, go online to:

To view CMS’s updated payment and HCPCS Level I CPT code structure for vaccine information, go to:

To view CMS’s FAQs page on Medicare FFS billing, go to:

Mark Spivey

Mark Spivey is a national correspondent for,, and Auditor Monitor who has been writing and editing material about the federal oversight of American healthcare for more than a decade. He can be reached at

This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Articles

  • As Hospitals Locked Down, Others Have Been Locked Out
    Leading case management during COVID-19. Towards the end of the most recent COVID-19 surge, an employee working from home mentioned how isolated they felt, and how lucky I was to go into work every day. That sat with me for…
  • Face to Virtual Face
    Expansion of telehealth services and vaccine news are included in this report. The Patient Protection and Affordable Care Act (PPACA) established a face-to-face encounter requirement for certification of eligibility for Medicare home health services, by requiring the certifying physician to…
  • COVID Crime Goes Viral
    Crime doesn’t pay, but it’s costing headaches for many. The COVID-19 vaccination program has stimulated one of the largest crime waves in history – and it also may turn out to be one of the most lucrative. For crooks, the…